DOI:
10.1055/s-00000032
Klinische Neurophysiologie
LinksClose Window
References
Thal LJ. et al.
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.
Neuropsychopharmacology 2005; 30: 1204-1215
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.